Skip to content

Drybench Patent.

Patent and exclusivity dates from January to June 2040 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from January to June 2040 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured
14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2040July to December 2040

Listed patent expiry (149)

  • 3 Jan 2040 · NDA 217294 · FUROSEMIDE

    US 11,246,851, product and use patent

    patent.txt line 19,838
    Flags
    product use code U-4576
    Product numbers
    001
  • 3 Jan 2040 · NDA 217294 · FUROSEMIDE

    US 12,318,363, product patent

    patent.txt line 19,839
    Flags
    product
    Product numbers
    001
  • 7 Jan 2040 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

    US 10,780,064, use patent

    patent.txt line 16,935
    Flags
    use code U-3419
    Product numbers
    001
  • 7 Jan 2040 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

    US 10,925,842, use patent

    patent.txt line 16,954
    Flags
    use code U-3419
    Product numbers
    001
  • 7 Jan 2040 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

    US 10,940,124, use patent

    patent.txt line 16,956
    Flags
    use code U-3419
    Product numbers
    001
  • 7 Jan 2040 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

    US 10,966,942, use patent

    patent.txt line 16,960
    Flags
    use code U-3419
    Product numbers
    001
  • 10 Jan 2040 · NDA 208743 · ABALOPARATIDE

    US 11,255,842, use patent

    patent.txt line 9,292
    Flags
    use code U-3322
    Product numbers
    001
  • 10 Jan 2040 · NDA 208743 · ABALOPARATIDE

    US 11,680,942, use patent

    patent.txt line 9,293
    Flags
    use code U-3322
    Product numbers
    001
  • 17 Jan 2040 · NDA 216986 · GADOPICLENOL

    US 11,590,246, product patent

    patent.txt lines 19,098, 19,102, 19,106, 19,110, 19,114, 19,118, 19,122
    Flags
    product
    Product numbers
    001, 002, 003, 004, 005, 006, 007
  • 17 Jan 2040 · NDA 216986 · GADOPICLENOL

    US 12,064,487, use patent

    patent.txt lines 19,099, 19,103, 19,107, 19,111, 19,115, 19,119, 19,123
    Flags
    use code U-4424
    Product numbers
    001, 002, 003, 004, 005, 006, 007
  • 22 Jan 2040 · NDA 213994 · EPHEDRINE SULFATE

    US 10,869,845, product patent

    patent.txt lines 15,422–15,423
    Flags
    product
    Product numbers
    001, 002
  • 22 Jan 2040 · NDA 213994 · EPHEDRINE SULFATE

    US 12,029,710, use patent

    patent.txt line 15,424
    Flags
    use code U-3963
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 11,497,755, product patent

    patent.txt line 11,093
    Flags
    product
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 11,559,535, product patent

    patent.txt line 11,094
    Flags
    product
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 11,571,434, product patent

    patent.txt line 11,095
    Flags
    product
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 11,998,555, product and use patent

    patent.txt line 11,096
    Flags
    product use code U-4589
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 12,048,709, product and use patent

    patent.txt line 11,097
    Flags
    product use code U-4588
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 12,491,193, product and use patent

    patent.txt line 11,098
    Flags
    product use code U-4588
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 12,491,194, product and use patent

    patent.txt line 11,099
    Flags
    product use code U-4588
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 12,491,195, product and use patent

    patent.txt line 11,100
    Flags
    product use code U-4588
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 12,491,196, product and use patent

    patent.txt line 11,101
    Flags
    product use code U-4588
    Product numbers
    002
  • 30 Jan 2040 · NDA 209988 · FUROSEMIDE

    US 12,491,197, product and use patent

    patent.txt line 11,102
    Flags
    product use code U-4588
    Product numbers
    002
  • 30 Jan 2040 · NDA 210951 · APALUTAMIDE

    US 11,963,952, use patent

    patent.txt lines 12,436, 12,454
    Flags
    use code U-3901
    Product numbers
    001, 002
  • 30 Jan 2040 · NDA 210951 · APALUTAMIDE

    US 12,303,497, use patent

    patent.txt lines 12,438, 12,456
    Flags
    use code U-4448
    Product numbers
    001, 002
  • 30 Jan 2040 · NDA 210951 · APALUTAMIDE

    US 12,303,497, use patent

    patent.txt lines 12,439, 12,457
    Flags
    use code U-4494
    Product numbers
    001, 002
  • 31 Jan 2040 · NDA 206030 · CARBAMAZEPINE

    US 11,529,357, product patent

    patent.txt line 6,070
    Flags
    product
    Product numbers
    001
  • 31 Jan 2040 · NDA 210833 · CLOBAZAM

    US 11,541,002, product and use patent

    patent.txt lines 12,160, 12,163, 12,166
    Flags
    product use code U-724
    Product numbers
    001, 002, 003
  • 3 Feb 2040 · NDA 219304 · VIMSELTINIB

    US 11,103,507, use patent

    patent.txt lines 21,594, 21,607, 21,620
    Flags
    use code U-4145
    Product numbers
    001, 002, 003
  • 3 Feb 2040 · NDA 219304 · VIMSELTINIB

    US 11,679,110, use patent

    patent.txt lines 21,595, 21,608, 21,621
    Flags
    use code U-4145
    Product numbers
    001, 002, 003
  • 4 Feb 2040 · NDA 220848 · ENLICITIDE DECANOATE

    US 11,427,616, substance and product and use patent

    patent.txt line 22,395
    Flags
    substance product use code U-4585
    Product numbers
    001
  • 11 Feb 2040 · NDA 210526 · AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

    US 12,458,592, use patent

    patent.txt lines 11,560, 11,566, 11,572, 11,578
    Flags
    use code U-3538
    Product numbers
    001, 002, 003, 004
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 11,229,647, use patent

    patent.txt line 15,922
    Flags
    use code U-3290
    Product numbers
    001
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 11,229,647, use patent

    patent.txt line 15,923
    Flags
    use code U-3974
    Product numbers
    001
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 11,497,745, use patent

    patent.txt line 15,929
    Flags
    use code U-3290
    Product numbers
    001
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 11,497,745, use patent

    patent.txt line 15,930
    Flags
    use code U-3974
    Product numbers
    001
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 11,918,578, use patent

    patent.txt line 15,931
    Flags
    use code U-3290
    Product numbers
    001
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 11,918,578, use patent

    patent.txt line 15,932
    Flags
    use code U-3974
    Product numbers
    001
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 12,599,602, use patent

    patent.txt line 15,933
    Flags
    use code U-3290
    Product numbers
    001
  • 12 Feb 2040 · NDA 214662 · MARALIXIBAT CHLORIDE

    US 12,599,602, use patent

    patent.txt line 15,934
    Flags
    use code U-3974
    Product numbers
    001
  • 12 Feb 2040 · NDA 219485 · MARALIXIBAT CHLORIDE

    US 11,229,647, use patent

    patent.txt lines 21,748, 21,757, 21,766, 21,775
    Flags
    use code U-4187
    Product numbers
    001, 002, 003, 004
  • 12 Feb 2040 · NDA 219485 · MARALIXIBAT CHLORIDE

    US 11,497,745, use patent

    patent.txt lines 21,752, 21,761, 21,770, 21,779
    Flags
    use code U-4187
    Product numbers
    001, 002, 003, 004
  • 18 Feb 2040 · NDA 211243 · ESKETAMINE HYDROCHLORIDE

    US 11,883,526, use patent

    patent.txt line 12,656
    Flags
    use code U-3812
    Product numbers
    001
  • 18 Feb 2040 · NDA 211243 · ESKETAMINE HYDROCHLORIDE

    US 11,883,526, use patent

    patent.txt line 12,657
    Flags
    use code U-3813
    Product numbers
    001
  • 18 Feb 2040 · NDA 211243 · ESKETAMINE HYDROCHLORIDE

    US 11,883,526, use patent

    patent.txt line 12,658
    Flags
    use code U-4120
    Product numbers
    001
  • 18 Feb 2040 · NDA 219293 · NILOTINIB TARTRATE

    US 10,874,671, product patent

    patent.txt lines 21,578, 21,582
    Flags
    product
    Product numbers
    001, 002
  • 18 Feb 2040 · NDA 219293 · NILOTINIB TARTRATE

    US 11,793,809, product patent

    patent.txt lines 21,579, 21,583
    Flags
    product
    Product numbers
    001, 002
  • 18 Feb 2040 · NDA 219293 · NILOTINIB TARTRATE

    US 12,403,140, product patent

    patent.txt lines 21,580, 21,584
    Flags
    product
    Product numbers
    001, 002
  • 18 Feb 2040 · NDA 219293 · NILOTINIB TARTRATE

    US 12,629,369, product patent

    patent.txt lines 21,581, 21,585
    Flags
    product
    Product numbers
    001, 002
  • 19 Feb 2040 · NDA 214510 · BENZOYL PEROXIDE

    US 10,933,046, product and use patent

    patent.txt line 15,815
    Flags
    product use code U-3357
    Product numbers
    001
  • 19 Feb 2040 · NDA 214510 · BENZOYL PEROXIDE

    US 10,945,987, use patent

    patent.txt line 15,816
    Flags
    use code U-3356
    Product numbers
    001
  • 19 Feb 2040 · NDA 214510 · BENZOYL PEROXIDE

    US 11,541,026, use patent

    patent.txt line 15,818
    Flags
    use code U-3356
    Product numbers
    001
  • 19 Feb 2040 · NDA 214510 · BENZOYL PEROXIDE

    US 11,865,100, use patent

    patent.txt line 15,820
    Flags
    use code U-3357
    Product numbers
    001
  • 19 Feb 2040 · NDA 214510 · BENZOYL PEROXIDE

    US 11,877,997, use patent

    patent.txt line 15,821
    Flags
    use code U-3356
    Product numbers
    001
  • 19 Feb 2040 · NDA 214510 · BENZOYL PEROXIDE

    US 11,986,456, use patent

    patent.txt line 15,822
    Flags
    use code U-3947
    Product numbers
    001
  • 21 Feb 2040 · NDA 217673 · BRENSOCATIB

    US 12,059,424, product patent

    patent.txt lines 20,220, 20,234
    Flags
    product
    Product numbers
    001, 002
  • 1 Mar 2040 · NDA 213593 · OMEPRAZOLE; SODIUM BICARBONATE

    US 11,771,686, use patent

    patent.txt line 15,155
    Flags
    use code U-623
    Product numbers
    001
  • 2 Mar 2040 · NDA 214133 · LEVOKETOCONAZOLE

    US 11,020,393, use patent

    patent.txt line 15,559
    Flags
    use code U-3282
    Product numbers
    001
  • 2 Mar 2040 · NDA 214133 · LEVOKETOCONAZOLE

    US 11,278,547, use patent

    patent.txt line 15,560
    Flags
    use code U-3282
    Product numbers
    001
  • 2 Mar 2040 · NDA 214133 · LEVOKETOCONAZOLE

    US 11,903,940, use patent

    patent.txt line 15,562
    Flags
    use code U-3821
    Product numbers
    001
  • 2 Mar 2040 · NDA 214133 · LEVOKETOCONAZOLE

    US 12,377,096, use patent

    patent.txt line 15,563
    Flags
    use code U-4236
    Product numbers
    001
  • 9 Mar 2040 · NDA 202293 · DAPAGLIFLOZIN

    US 10,973,836, use patent

    patent.txt line 3,004
    Flags
    use code U-3127
    Product numbers
    002
  • 9 Mar 2040 · NDA 202293 · DAPAGLIFLOZIN

    US 11,903,955, use patent

    patent.txt line 3,008
    Flags
    use code U-3825
    Product numbers
    002
  • 17 Mar 2040 · NDA 215239 · VAMOROLONE

    US 11,471,471, use patent

    patent.txt line 16,592
    Flags
    use code U-3747
    Product numbers
    001
  • 17 Mar 2040 · NDA 215239 · VAMOROLONE

    US 12,201,639, substance and product and use patent

    patent.txt line 16,595
    Flags
    substance product use code U-3747
    Product numbers
    001
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 10,940,133, use patent

    patent.txt line 12,561
    Flags
    use code U-3099
    Product numbers
    001
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,160,779, use patent

    patent.txt lines 12,563, 12,604
    Flags
    use code U-3521
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,839,598, use patent

    patent.txt lines 12,572, 12,613
    Flags
    use code U-3765
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,839,599, use patent

    patent.txt lines 12,573, 12,614
    Flags
    use code U-3764
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,850,226, use patent

    patent.txt lines 12,574, 12,615
    Flags
    use code U-3775
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,850,227, use patent

    patent.txt lines 12,575, 12,616
    Flags
    use code U-3775
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,850,228, use patent

    patent.txt lines 12,576, 12,617
    Flags
    use code U-3775
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,857,528, use patent

    patent.txt lines 12,577, 12,618
    Flags
    use code U-3521
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,969,404, use patent

    patent.txt lines 12,581, 12,622
    Flags
    use code U-3892
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,986,454, use patent

    patent.txt lines 12,582, 12,623
    Flags
    use code U-3775
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 11,986,455, use patent

    patent.txt lines 12,583, 12,624
    Flags
    use code U-3521
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 12,194,016, use patent

    patent.txt lines 12,590, 12,631
    Flags
    use code U-4106
    Product numbers
    001, 002
  • 19 Mar 2040 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE

    US 12,318,362, use patent

    patent.txt line 12,593
    Flags
    use code U-3765
    Product numbers
    001
  • 22 Mar 2040 · NDA 213006 · VIBEGRON

    US 12,102,638, use patent

    patent.txt line 14,564
    Flags
    use code U-3045
    Product numbers
    001
  • 10 Apr 2040 · NDA 212608 · AVAPRITINIB

    US 11,964,980, substance and product patent

    patent.txt lines 14,186, 14,195, 14,204, 14,210, 14,220
    Flags
    substance product
    Product numbers
    001, 002, 003, 004, 005
  • 10 Apr 2040 · NDA 212608 · AVAPRITINIB

    US 11,999,744, use patent

    patent.txt lines 14,187, 14,196, 14,211, 14,221
    Flags
    use code U-3168
    Product numbers
    001, 002, 004, 005
  • 10 Apr 2040 · NDA 212608 · AVAPRITINIB

    US 11,999,744, use patent

    patent.txt line 14,212
    Flags
    use code U-3506
    Product numbers
    004
  • 10 Apr 2040 · NDA 212608 · AVAPRITINIB

    US 12,252,494, use patent

    patent.txt line 14,213
    Flags
    use code U-3506
    Product numbers
    004
  • 14 Apr 2040 · NDA 220641 · RELACORILANT

    US 11,464,764, product patent

    patent.txt line 22,367
    Flags
    product
    Product numbers
    001
  • 16 Apr 2040 · NDA 211950 · TRIAMCINOLONE ACETONIDE

    US 12,419,833, product and use patent

    patent.txt line 13,246
    Flags
    product use code U-3234
    Product numbers
    001
  • 16 Apr 2040 · NDA 219847 · LISDEXAMFETAMINE DIMESYLATE

    US 12,433,859, product and use patent

    patent.txt line 22,024
    Flags
    product use code U-842
    Product numbers
    001
  • 16 Apr 2040 · NDA 219847 · LISDEXAMFETAMINE DIMESYLATE

    US 12,582,620, product patent

    patent.txt line 22,025
    Flags
    product
    Product numbers
    001
  • 27 Apr 2040 · NDA 219097 · IMATINIB MESYLATE

    US 11,957,681, product patent

    patent.txt line 21,495
    Flags
    product
    Product numbers
    001
  • 3 May 2040 · NDA 217865 · GIVINOSTAT HYDROCHLORIDE

    US 12,606,519, substance and product patent

    patent.txt line 20,748
    Flags
    substance product
    Product numbers
    001
  • 9 May 2040 · NDA 215431 · MELOXICAM; RIZATRIPTAN BENZOATE

    US 12,685,736, use patent

    patent.txt line 17,273
    Flags
    use code U-1719
    Product numbers
    001
  • 13 May 2040 · NDA 215256 · SEMAGLUTIDE

    US 11,478,533, use patent

    patent.txt lines 16,605, 16,613, 16,621, 16,629, 16,637, 16,657, 16,669, 16,681, 16,693, 16,705, 16,713
    Flags
    use code U-3861
    Product numbers
    001, 002, 003, 004, 005, 007, 008, 009, 010, 011, 012
  • 14 May 2040 · NDA 215358 · ASCIMINIB HYDROCHLORIDE

    US 11,407,735, substance patent

    patent.txt lines 16,806, 16,810, 16,814
    Flags
    substance
    Product numbers
    001, 002, 003
  • 14 May 2040 · NDA 215358 · ASCIMINIB HYDROCHLORIDE

    US 12,252,478, product patent

    patent.txt lines 16,807, 16,811, 16,815
    Flags
    product
    Product numbers
    001, 002, 003
  • 14 May 2040 · NDA 219008 · LAZERTINIB MESYLATE

    US 12,599,606, use patent

    patent.txt line 21,442
    Flags
    use code U-4512
    Product numbers
    001
  • 14 May 2040 · NDA 219008 · LAZERTINIB MESYLATE

    US 12,599,606, use patent

    patent.txt line 21,451
    Flags
    use code U-4511
    Product numbers
    002
  • 16 May 2040 · NDA 213407 · EPHEDRINE SULFATE

    US 11,090,278, use patent

    patent.txt line 14,975
    Flags
    use code U-3183
    Product numbers
    001
  • 16 May 2040 · NDA 213407 · EPHEDRINE SULFATE

    US 11,241,400, use patent

    patent.txt line 14,976
    Flags
    use code U-3183
    Product numbers
    001
  • 16 May 2040 · NDA 213407 · EPHEDRINE SULFATE

    US 11,464,752, product patent

    patent.txt lines 14,977, 14,980
    Flags
    product
    Product numbers
    001, 002
  • 16 May 2040 · NDA 213407 · EPHEDRINE SULFATE

    US 11,478,436, use patent

    patent.txt line 14,978
    Flags
    use code U-3183
    Product numbers
    001
  • 16 May 2040 · NDA 213407 · EPHEDRINE SULFATE

    US 11,571,398, use patent

    patent.txt lines 14,979, 14,981
    Flags
    use code U-3183
    Product numbers
    001, 002
  • 17 May 2040 · NDA 215358 · ASCIMINIB HYDROCHLORIDE

    US 12,252,479, use patent

    patent.txt lines 16,808, 16,812, 16,816
    Flags
    use code U-1374
    Product numbers
    001, 002, 003
  • 19 May 2040 · NDA 219627 · GADOQUATRANE

    US 11,944,690, product patent

    patent.txt lines 21,817, 21,823, 21,829, 21,835, 21,841, 21,847
    Flags
    product
    Product numbers
    001, 002, 003, 004, 005, 006
  • 20 May 2040 · NDA 214665 · SOTORASIB

    US 11,236,091, substance and product and use patent

    patent.txt lines 15,939, 15,949, 15,959
    Flags
    substance product use code U-3306
    Product numbers
    001, 002, 003
  • 20 May 2040 · NDA 214665 · SOTORASIB

    US 11,236,091, substance and product and use patent

    patent.txt lines 15,940, 15,950, 15,960
    Flags
    substance product use code U-4107
    Product numbers
    001, 002, 003
  • 20 May 2040 · NDA 214665 · SOTORASIB

    US 11,827,635, substance and product and use patent

    patent.txt lines 15,943, 15,953, 15,963
    Flags
    substance product use code U-3306
    Product numbers
    001, 002, 003
  • 20 May 2040 · NDA 214665 · SOTORASIB

    US 11,827,635, substance and product and use patent

    patent.txt lines 15,944, 15,954, 15,964
    Flags
    substance product use code U-4107
    Product numbers
    001, 002, 003
  • 20 May 2040 · NDA 214665 · SOTORASIB

    US 12,398,133, substance and product and use patent

    patent.txt lines 15,946, 15,956, 15,966
    Flags
    substance product use code U-3306
    Product numbers
    001, 002, 003
  • 20 May 2040 · NDA 214665 · SOTORASIB

    US 12,398,133, substance and product and use patent

    patent.txt lines 15,947, 15,957, 15,967
    Flags
    substance product use code U-4107
    Product numbers
    001, 002, 003
  • 21 May 2040 · NDA 219008 · LAZERTINIB MESYLATE

    US 11,879,013, use patent

    patent.txt lines 21,438, 21,447
    Flags
    use code U-3985
    Product numbers
    001, 002
  • 22 May 2040 · NDA 217347 · SOFPIRONIUM BROMIDE

    US 11,566,000, substance and product patent

    patent.txt line 19,855
    Flags
    substance product
    Product numbers
    001
  • 22 May 2040 · NDA 217347 · SOFPIRONIUM BROMIDE

    US 11,584,715, substance and product patent

    patent.txt line 19,856
    Flags
    substance product
    Product numbers
    001
  • 22 May 2040 · NDA 217347 · SOFPIRONIUM BROMIDE

    US 12,703,682, substance and product patent

    patent.txt line 19,860
    Flags
    substance product
    Product numbers
    001
  • 28 May 2040 · NDA 215431 · MELOXICAM; RIZATRIPTAN BENZOATE

    US 12,128,052, use patent

    patent.txt line 17,262
    Flags
    use code U-1719
    Product numbers
    001
  • 28 May 2040 · NDA 215431 · MELOXICAM; RIZATRIPTAN BENZOATE

    US 12,551,488, use patent

    patent.txt line 17,269
    Flags
    use code U-1719
    Product numbers
    001
  • 28 May 2040 · NDA 215431 · MELOXICAM; RIZATRIPTAN BENZOATE

    US 12,551,489, use patent

    patent.txt line 17,270
    Flags
    use code U-1719
    Product numbers
    001
  • 29 May 2040 · NDA 213702 · LURBINECTEDIN

    US 12,324,806, use patent

    patent.txt line 15,207
    Flags
    use code U-4212 delist requested
    Product numbers
    001
  • 29 May 2040 · NDA 213702 · LURBINECTEDIN

    US 12,433,890, use patent

    patent.txt line 15,208
    Flags
    use code U-4305 delist requested
    Product numbers
    001
  • 29 May 2040 · NDA 213702 · LURBINECTEDIN

    US 12,440,490, use patent

    patent.txt line 15,209
    Flags
    use code U-4252 delist requested
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 11,596,634, use patent

    patent.txt line 21,407
    Flags
    use code U-4271
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 11,596,634, use patent

    patent.txt line 21,408
    Flags
    use code U-4272
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 11,596,634, use patent

    patent.txt line 21,409
    Flags
    use code U-4273
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 11,612,566, use patent

    patent.txt line 21,410
    Flags
    use code U-4271
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 11,612,566, use patent

    patent.txt line 21,411
    Flags
    use code U-4272
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 11,612,566, use patent

    patent.txt line 21,412
    Flags
    use code U-4273
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 12,629,377, product and use patent

    patent.txt line 21,413
    Flags
    product use code U-4539
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 12,629,377, product and use patent

    patent.txt line 21,414
    Flags
    product use code U-4540
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 12,629,377, product and use patent

    patent.txt line 21,415
    Flags
    product use code U-4541
    Product numbers
    001
  • 29 May 2040 · NDA 218879 · LAMOTRIGINE

    US 12,636,289, product patent

    patent.txt line 21,416
    Flags
    product
    Product numbers
    001
  • 5 Jun 2040 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

    US 12,433,884, use patent

    patent.txt lines 17,069, 17,153
    Flags
    use code U-4514
    Product numbers
    001, 002
  • 5 Jun 2040 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

    US 12,472,156, use patent

    patent.txt lines 17,071, 17,154
    Flags
    use code U-4516
    Product numbers
    001, 002
  • 5 Jun 2040 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE

    US 12,576,078, use patent

    patent.txt lines 17,075, 17,156
    Flags
    use code U-4516
    Product numbers
    001, 002
  • 5 Jun 2040 · NDA 216185 · LACOSAMIDE

    US 11,337,943, product and use patent

    patent.txt lines 18,412, 18,418, 18,424
    Flags
    product use code U-3660
    Product numbers
    001, 002, 003
  • 5 Jun 2040 · NDA 216185 · LACOSAMIDE

    US 11,337,943, product and use patent

    patent.txt lines 18,413, 18,419, 18,425
    Flags
    product use code U-3954
    Product numbers
    001, 002, 003
  • 5 Jun 2040 · NDA 216185 · LACOSAMIDE

    US 11,883,374, product and use patent

    patent.txt lines 18,414, 18,420, 18,426
    Flags
    product use code U-3660
    Product numbers
    001, 002, 003
  • 5 Jun 2040 · NDA 216185 · LACOSAMIDE

    US 11,883,374, product and use patent

    patent.txt lines 18,415, 18,421, 18,427
    Flags
    product use code U-3954
    Product numbers
    001, 002, 003
  • 5 Jun 2040 · NDA 216185 · LACOSAMIDE

    US 12,042,474, product and use patent

    patent.txt lines 18,416, 18,422, 18,428
    Flags
    product use code U-3660
    Product numbers
    001, 002, 003
  • 5 Jun 2040 · NDA 216185 · LACOSAMIDE

    US 12,042,474, product and use patent

    patent.txt lines 18,417, 18,423, 18,429
    Flags
    product use code U-3954
    Product numbers
    001, 002, 003
  • 10 Jun 2040 · NDA 215309 · RUXOLITINIB PHOSPHATE

    US 11,590,138, use patent

    patent.txt line 16,749
    Flags
    use code U-3551
    Product numbers
    001
  • 10 Jun 2040 · NDA 216962 · FOSCARBIDOPA; FOSLEVODOPA

    US 12,251,365, use patent

    patent.txt line 19,085
    Flags
    use code U-4030
    Product numbers
    001
  • 10 Jun 2040 · NDA 218785 · ZANUBRUTINIB

    US 12,233,069, product patent

    patent.txt line 21,369
    Flags
    product
    Product numbers
    001
  • 19 Jun 2040 · NDA 211616 · BEMPEDOIC ACID

    US 11,613,511, substance patent

    patent.txt line 12,891
    Flags
    substance
    Product numbers
    001
  • 19 Jun 2040 · NDA 211616 · BEMPEDOIC ACID

    US 11,760,714, product patent

    patent.txt line 12,893
    Flags
    product
    Product numbers
    001
  • 19 Jun 2040 · NDA 211616 · BEMPEDOIC ACID

    US 11,926,584, use patent

    patent.txt line 12,894
    Flags
    use code U-3873
    Product numbers
    001
  • 19 Jun 2040 · NDA 211616 · BEMPEDOIC ACID

    US 12,398,087, substance and product patent

    patent.txt line 12,895
    Flags
    substance product
    Product numbers
    001
  • 19 Jun 2040 · NDA 211616 · BEMPEDOIC ACID

    US 12,404,227, substance and use patent

    patent.txt line 12,896
    Flags
    substance use code U-4258
    Product numbers
    001
  • 19 Jun 2040 · NDA 211617 · BEMPEDOIC ACID; EZETIMIBE

    US 11,613,511, substance patent

    patent.txt line 12,900
    Flags
    substance
    Product numbers
    001
  • 19 Jun 2040 · NDA 211617 · BEMPEDOIC ACID; EZETIMIBE

    US 11,760,714, product patent

    patent.txt line 12,903
    Flags
    product
    Product numbers
    001
  • 19 Jun 2040 · NDA 211617 · BEMPEDOIC ACID; EZETIMIBE

    US 11,926,584, use patent

    patent.txt line 12,904
    Flags
    use code U-3873
    Product numbers
    001
  • 19 Jun 2040 · NDA 211617 · BEMPEDOIC ACID; EZETIMIBE

    US 12,398,087, substance and product patent

    patent.txt line 12,905
    Flags
    substance product
    Product numbers
    001
  • 19 Jun 2040 · NDA 211617 · BEMPEDOIC ACID; EZETIMIBE

    US 12,404,227, substance and use patent

    patent.txt line 12,906
    Flags
    substance use code U-4258
    Product numbers
    001

Pediatric exclusivity, as listed (26)

  • 18 Jan 2040 · NDA 202293 · DAPAGLIFLOZIN

    US 11,826,376 with pediatric exclusivity, as listed

    patent.txt line 3,005
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    002
  • 18 Jan 2040 · NDA 202293 · DAPAGLIFLOZIN

    US 12,472,194 with pediatric exclusivity, as listed

    patent.txt line 3,013
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    002
  • 20 Feb 2040 · NDA 208798 · FLUTICASONE PROPIONATE

    US 11,969,544 with pediatric exclusivity, as listed

    patent.txt lines 9,465, 9,469, 9,473, 9,483, 9,493, 9,503, 9,507, 9,517
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 20 Feb 2040 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

    US 11,969,544 with pediatric exclusivity, as listed

    patent.txt lines 9,521, 9,529, 9,535, 9,547, 9,561, 9,573
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006
  • 26 Mar 2040 · NDA 208798 · FLUTICASONE PROPIONATE

    US 11,344,685 with pediatric exclusivity, as listed

    patent.txt lines 9,481, 9,491, 9,501, 9,515
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    004, 005, 006, 008
  • 26 Mar 2040 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

    US 11,344,685 with pediatric exclusivity, as listed

    patent.txt lines 9,545, 9,559, 9,571
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    004, 005, 006
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,662,160 with pediatric exclusivity, as listed

    patent.txt lines 15,467, 15,499
    Flags
    substance pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,117,867 with pediatric exclusivity, as listed

    patent.txt lines 15,471, 15,503
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,618,733 with pediatric exclusivity, as listed

    patent.txt lines 15,475, 15,507
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,344,585 with pediatric exclusivity, as listed

    patent.txt lines 15,481, 15,513
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,545,645 with pediatric exclusivity, as listed

    patent.txt lines 15,483, 15,515
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,545,646 with pediatric exclusivity, as listed

    patent.txt lines 15,485, 15,517
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,545,647 with pediatric exclusivity, as listed

    patent.txt lines 15,487, 15,519
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,552,750 with pediatric exclusivity, as listed

    patent.txt lines 15,489, 15,521
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,590,068 with pediatric exclusivity, as listed

    patent.txt lines 15,491, 15,523
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,590,069 with pediatric exclusivity, as listed

    patent.txt lines 15,493, 15,525
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,662,160 with pediatric exclusivity, as listed

    patent.txt lines 21,884, 21,916, 21,948, 21,980
    Flags
    substance pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,117,867 with pediatric exclusivity, as listed

    patent.txt lines 21,888, 21,920, 21,952, 21,984
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,618,733 with pediatric exclusivity, as listed

    patent.txt lines 21,892, 21,924, 21,956, 21,988
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,344,585 with pediatric exclusivity, as listed

    patent.txt lines 21,898, 21,930, 21,962, 21,994
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,545,645 with pediatric exclusivity, as listed

    patent.txt lines 21,900, 21,932, 21,964, 21,996
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,545,646 with pediatric exclusivity, as listed

    patent.txt lines 21,902, 21,934, 21,966, 21,998
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,545,647 with pediatric exclusivity, as listed

    patent.txt lines 21,904, 21,936, 21,968, 22,000
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,552,750 with pediatric exclusivity, as listed

    patent.txt lines 21,906, 21,938, 21,970, 22,002
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,590,068 with pediatric exclusivity, as listed

    patent.txt lines 21,908, 21,940, 21,972, 22,004
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 1 May 2040 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,590,069 with pediatric exclusivity, as listed

    patent.txt lines 21,910, 21,942, 21,974, 22,006
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004